Economic evaluation of endothelial keratoplasty techniques and penetrating keratoplasty in the Netherlands

American Journal of Ophthalmology

Volumn 154, Issue 2, 2012, Pages

  Van Den Biggelaar, Frank J H M ^a   Cheng, Yanny Y Y ^a   Nuijts, Rudy M M A ^a   Schouten, Jan S A G ^a   Wijdh, Robert Jan ^b   Pels, Elisabeth ^c   Van Cleynenbreugel, Hugo ^d   Eggink, Catharina A ^e   Rijneveld, Wilhelmina J ^f   Dirksen, Carmen D ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Euro Tissue Bank ^*  (Netherlands)

^d ROTTERDAM EYE HOSPITAL   (Netherlands)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f Westfriesgasthuis ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ASTIGMATISM; CONGENITAL CORNEA DYSTROPHY; CORNEAL ENDOTHELIAL CELL LOSS; COST BENEFIT ANALYSIS; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; FEMALE; FEMTOSECOND LASER; FEMTOSECOND LASER ASSISTED DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; IRIDOCORNEAL ENDOTHELIAL SYNDROME; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NETHERLANDS; PENETRATING KERATOPLASTY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; VISUAL ACUITY;

EID: 84866383190     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.02.023     Document Type: Article

References (42)

1. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr. Long-term graft survival after penetrating keratoplasty. Ophthalmology 2003;110(7):1396 -1402.
2. Beckingsale P, Mavrikakis I, Al-Yousuf N, Mavrikakis E, Daya SM. Penetrating keratoplasty: outcomes from a corneal unit compared to national data. Br J Ophthalmol 2006; 90(6):728 -731.
3. Williams KA, Esterman AJ, Bartlett C, Holland H, Hornsby NB, Coster DJ. How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation 2006;81(6):896 -901.
4. Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea 2006;25(8):886-889.
5. Terry MA, Ousley PJ. Deep lamellar endothelial keratoplasty in the first United States patients: early clinical results. Cornea 2001;20(3):239 -243.
6. Price FW Jr, Price MO. Descemet's stripping with endothelial keratoplasty in 200 eyes: Early challenges and techniques to enhance donor adherence. J Cataract Refract Surg 2006; 32(3):411-418.
7. Bahar I, Kaiserman I, McAllum P, Slomovic A, Rootman D. Comparison of posterior lamellar keratoplasty techniques to penetrating keratoplasty. Ophthalmology 2008;115(9): 1525-1533.
8. Koenig SB, Covert DJ, Dupps WJ Jr, Meisler DM. Visual acuity, refractive error, and endothelial cell density six months after Descemet stripping and automated endothelial keratoplasty (DSAEK). Cornea 2007;26(6):670-674.
9. Terry MA, Chen ES, Shamie N, Hoar KL, Friend DJ. Endothelial cell loss after Descemet's stripping endothelial keratoplasty in a large prospective series. Ophthalmology 2008;115(3):488-496.e483.
10. Mearza AA, Qureshi MA, Rostron CK. Experience and 12-month results of descemet-stripping endothelial kerato- plasty (DSEK) with a small-incision technique. Cornea 2007;26(3):279 -283.
11. Cheng YY, Tahzib NG, van Rij G, et al. Femtosecond laser-assisted inverted mushroom keratoplasty. Cornea 2008(6);27:679-685.
12. Price MO, Baig KM, Brubaker JW, Price FW Jr. Randomized, prospective comparison of precut vs surgeon-dissected grafts for descemet stripping automated endothelial keratoplasty. Am J Ophthalmol 2008(1);146:36-41.
13. Cheng YY, Hendrikse F, Pels E, et al. Preliminary results of femtosecond laser-assisted descemet stripping endothelial keratoplasty. Arch Ophthalmol 2008;126(10):1351-1356.
14. Cheng YY, Kang SJ, Grossniklaus HE, et al. Histologic evaluation of human posterior lamellar discs for femtosecond laser Descemet's stripping endothelial keratoplasty. Cornea 2009;28(1):73-79.
15. Cheng YY, Pels E, Nuijts RM. Femtosecond-laser-assisted Descemet's stripping endothelial keratoplasty. J Cataract Refract Surg 2007;33(1):152-155.
16. Cheng YY, Schouten JS, Tahzib NG, et al. Efficacy and safety of femtosecond laser-assisted corneal endothelial keratoplasty: a randomized multicenter clinical trial. Transplantation 2009;88(11):1294 -1302.
17. McLaren JW, Patel SV, Bourne WM, Baratz KH. Corneal wavefront errors 24 months after deep lamellar endothelial keratoplasty and penetrating keratoplasty. Am J Ophthalmol 2009;147(6):959 -965, 965.e1-2.
18. Patel SV, McLaren JW, Hodge DO, Baratz KH. Scattered light and visual function in a randomized trial of deep lamellar endothelial keratoplasty and penetrating keratoplasty. Am J Ophthalmol 2008;145(1):97-105.
19. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford: Oxford University Press; 2005.
20. Cheng YY, van Den Berg TJ, Schouten JS, et al. Quality of vision after femtosecond laser-assisted Descemet stripping endothelial keratoplasty and penetrating keratoplasty: a randomized, multicenter clinical trial. Am J Ophthalmol 2011; 152(4):556 -566.
21. Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94(1):91-96.
22. McKean-Cowdin R, Varma R, Hays RD, Wu J, Choudhury F, Azen SP. Longitudinal changes in visual acuity and health-related quality of life: the Los Angeles Latino Eye Study. Ophthalmology 2010;117(10):1900 -1907, 1907.e1.
23. Submacular Surgery Trials Research Group. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEIVFQ) SST Report Number 19. Ophthalmic Epidemiol 2007; 14(4):205-215.
24. Frost NA, Wu J, Lai TF, Coster DJ. A review of randomized controlled trials of penetrating keratoplasty techniques. Ophthalmology 2006;113(6):942-949.
25. Lindblad AS, Clemons TE. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Arch Ophthalmol 2005;123(9):1207-1214.
26. Miskala PH, Bass EB, Bressler NM, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no. 12. Ophthalmology 2004;111(11):1981-1992.
27. Miskala PH, Hawkins BS, Mangione CM, et al. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization - SST Report No. 1. Arch Ophthalmol 2003;121(4):531-539.
28. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH. Handleiding voor Kostenonderzoek: Methoden en Standaard Kostprijzen voor Economische Evaluaties in de Gezondheidszorg. Diemen: College voor Zorgverzekeringen; 2010.
29. Organization for Economic Co-operation and Development. Table 4: PPP and Exchange Rates. Available at: http://Stats.Oecd.Org/Index.Aspx?Datasetcode-Sna- Table4. Accessed: January 7, 2012.
30. Dutch Health Care Insurance Board. Pharmacotherapeutic Compass [in Dutch]. Amstelveen: College voor Zorgverzekeringen; 2008.
31. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000;19(23):3219 -3236.
32. Postma MJ, de Vries R, Welte R, Edmunds WJ. Health economic methodology illustrated with recent work on Chlamydia screening: the concept of extended dominance. Sex Transm Infect 2008;84(2):152-154.
33. Glick HA, Doshi J, Sonnad S, Polsky D. Economic evaluation in clinical trials. New York: Oxford University Press; 2007:133-144.
34. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ 2004;13(5):405-415.
35. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10(8):779 -787.
36. Drummond MF, Sculpher MJ, Torrance GW, O'Brein BJ, Stoddart GL. Methods for Economic Evaluation of Health Care Programmes. 3rd ed. Oxford: Oxford University Press; 2005:105.
37. Brown MM, Brown GC, Sharma S, Landy J. Health care economic analyses and value-based medicine. Surv Ophthalmol 2003;48(2):204 -223.
38. Council for Public Health and Health Care. Sensible and sustainable care [in Dutch]. The Netherlands: Den Haag; 2006.
39. Beauchemin C, Brunette I, Boisjoly H, Freeman EE, Popescu M, Lachaine J. Economic impact of the advent of posterior lamellar keratoplasty in Montreal, Quebec. Can J Ophthalmol 2010;45(3):243-251.
40. van den Biggelaar FJ, Cheng YY, Nuijts RM, et al. Economic evaluation of deep anterior lamellar keratoplasty versus penetrating keratoplasty in The Netherlands. Am J Ophthalmol 2011(3);151:449-459.e442.
41. Price MO, Jordan CS, Moore G, Price FW Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors. Br J Ophthalmol 2009;93(3):391-395.
42. Allan BD, Terry MA, Price FW Jr, Price MO, Griffin NB, Claesson M. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea 2007;26(9):1039-1042.